Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center
About this trial
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observe side effects that may happen to patients with advanced cancer who are treated with anti-VEGF related therapy. This may help doctors learn if there are any relationships between these side effects and how the disease may respond to treatment.
Eligibility criteria
Qualifiers
Patients must be able to understand and be willing to sign a written informed consent document
Patients must be receiving any anti-VEGF-related regimen in monotherapy or combination therapy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Electronic Health Record Review
Treatment groups
170 Participants
are divided into 1 treatment groupLocations
1M D Anderson Cancer Center77030, HoustonTexas, United States
Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
Source ClinicalTrials.gov